Bone marrow transplant in Iran

Share This Post

Bone marrow transplant is one of the services of Cancerfax, which is provided by the best surgeons, along with accommodation, a translator, a companion nurse, and a city tour at an affordable price in Iran.

What is leukemia?

Leukemia is usually thought of as a children’s condition, but it affects more adults. It’s more common in men than women and more in whites. There’s nothing you can do to prevent leukemia. It’s the cancer of your blood cells caused by a rise in the number of white blood cells in your body. They crowd out the red blood cells and platelets your body needs to be healthy. All those extra white blood cells don’t work right, and that causes problems.

What is a bone-marrow transplant (BMT)?

Bone-marrow transplantation replaces stem cells. It is used when stem cells or bone marrow have been damaged or destroyed by diseases, including some types of cancer, and leukemia, or by high doses of chemotherapy or radiation therapy.

What are the different types of BMT?

There are two main types of BMT: autologous and allogeneic bone marrow transplants. In Autologous, stem cells are taken from your child but in Allogeneic, the donor is another person. Other transplantation methods, such as umbilical cord blood, are also available, in which stem cells are taken from an umbilical cord right after a baby’s birth. These stem cells grow into mature blood cells quicker and more effectively than stem cells from the bone marrow of another child or adult. The stem cells are tested, typed, counted, and frozen in the transplantation bank until they are needed for a transplant.

Bone Marrow Transplant

Over the last decade, medicine has seen great advances in the diagnosis and treatment of cancer. Many people with the disease are living longer and many are cured. That’s thanks to cancer research and people who are willing to make sacrifices. Sacrifices such as donating bone marrow.

How long are you in the hospital after surgery?

Rehabilitation time for a patient to return to normal status varies depending on the patient’s condition and the transplant type, but it usually lasts about 2 to 6 weeks. During this time you have to stay in the hospital or visit the transplant center daily for at least a few weeks.

What are the side effects after BMT?

• Infections
• Low levels of platelets (thrombocytopenia) and red blood cells (anemia)
• Pain
• Diarrhea, nausea, and vomiting
• Breathing problems
• Organ damage: Short-term (temporary) liver and heart damage
• Graft failure
• Graft-versus-host disease(GVHD)

What are preparations before surgery?

Your doctor will want to make sure your body is strong enough to go through a bone marrow transplant. The tests needed to be done that could be continued over several days including:
• Blood tests to see how well your liver and kidneys are working and to make sure you don’t have an infectious disease
• Chest X-rays to look for signs of lung disease or infection
• Electrocardiogram (EKG) to check your heart’s rhythm
• Echocardiogram (Echo) to look for problems in your heart and the blood vessels around it
• CT scan to see how healthy your organs are
• Biopsy to help your doctor predict if your cancer is likely to come back after the transplant.
Putting a catheter (a long thin tube) into a large vein in your neck or chest that will stay there throughout your transplant. This will make it easier to give you medicine. You also might get new healthy bone marrow cells through it.
Chemotherapy and Radiation: Before the transplant, you’ll need to do chemotherapy and possibly radiation to kill cancer cells in your body and make room for new stem cells. They also slow down your immune system so your body’s more likely to accept the transplant.

Why Iran?

Even though performing bone marrow transplants in Iran is cost-effective, proceeding treatment with expert specialists and professional medical care teams along with developed technology improve the rank of Iran up to the third country for doing BMT among all other countries with the same technology in the world. There is a full and developed bone marrow and stem cell transplant bank in Iran. Also, blood banks and other organ transplantation are fully active in our country. By considering the cost of accommodation and food during rehabilitation which is much lower than Asian and European countries, Iran is an ideal country for doing bone marrow transplants.

Comparison of bone marrow transplantation between Iran and other countries

Currently, a few countries such as India, Mexico, the USA, Turkey, Jordan, S.Korea, Germany, and Iran have the specialty and technology to perform bone marrow transplantation. Generally, Stem Cells transplant or BMT is very expensive in the USA or European countries. For example, it costs more than 300,000 $ in Europe. While the cost of bone marrow transplant in Iran is estimated at about 60,000 $ which is significantly lower than even other Asian countries such as India which is predicted to be more than 83000 $.

If you would like the best surgeons in Iran’s first-class hospitals to perform your surgery, and at the same time be comfortable and stress-free during your treatment and stay in Iran at a reasonable cost, like your home, get in touch with Cancerfax Consultants. 

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Adagrasib with cetuximab has received accelerated approval by FDA for KRAS G12C-mutated colorectal cancer
Colon cancer

Adagrasib with cetuximab has received accelerated approval by FDA for KRAS G12C-mutated colorectal cancer

The FDA has granted accelerated approval to Adagrasib combined with Cetuximab for treating KRAS G12C-mutated colorectal cancer. This approval is based on promising clinical trial results showing enhanced efficacy of the drug duo. Adagrasib, a KRAS inhibitor, and Cetuximab, an EGFR inhibitor, together target the cancer more effectively, offering new hope for patients with this specific genetic mutation, aiming to improve survival rates and treatment outcomes.

Pembrolizumab with chemotherapy is approved by the USFDA for primary advanced or recurrent endometrial carcinoma
Endometrial cancer

Pembrolizumab with chemotherapy is approved by the USFDA for primary advanced or recurrent endometrial carcinoma

The USFDA has approved Pembrolizumab combined with chemotherapy for treating primary advanced or recurrent endometrial carcinoma. This approval is based on clinical trial data showing significant improvements in patient outcomes. Pembrolizumab, an immune checkpoint inhibitor, works by enhancing the body’s immune response against cancer cells. This combination therapy offers a new and promising treatment option for patients facing this challenging and often aggressive cancer.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy